Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/59857
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJohann Cailholen_US
dc.contributor.authorGonzague Jourdainen_US
dc.contributor.authorSophie Le Coeuren_US
dc.contributor.authorPatrinee Traisathiten_US
dc.contributor.authorKamol Boonroden_US
dc.contributor.authorSinart Prommasen_US
dc.contributor.authorChaiwat Putiyanunen_US
dc.contributor.authorAnnop Kanjanasingen_US
dc.contributor.authorMarc Lallemanten_US
dc.date.accessioned2018-09-10T03:22:35Z-
dc.date.available2018-09-10T03:22:35Z-
dc.date.issued2009-04-01en_US
dc.identifier.issn15254135en_US
dc.identifier.other2-s2.0-64249155675en_US
dc.identifier.other10.1097/QAI.0b013e3181958560en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=64249155675&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/59857-
dc.description.abstractObjective: Each year, intrauterine growth retardation (IUGR) affects 20-30 million neonates worldwide, mostly in resource-limited settings. Increased perinatal and infant mortality has been associated with IUGR. Some studies have suggested that HIV infection could increase the risk of IUGR. To confirm this hypothesis, we examined the association between HIV-related factors and the risk of IUGR in Thailand. Patients and Methods: Data from a cohort of 1436 HIV-infected pregnant women enrolled in the "Perinatal HIV Prevention Trial-1", a clinical trial conducted from 1997 to 1999 in Thailand, were analyzed using a logistic regression, adjusting for risk factors usually associated with IUGR. Results: The rate of IUGR was 7.6%. Adjusting for a short maternal height, low body mass index, small weight gain during pregnancy, and infant female sex, a low maternal CD4 percentage was independently associated with IUGR (odds ratio 0.96, per 1% increment, 95% confidence interval 0.93 to 0.99, P = 0.03). Conclusions: The current World Health Organization recommendation to initiate combination antiretroviral therapy for immunocompromised women as early as possible during pregnancy for their own health and for the prevention of HIV mother-to-child transmission is likely to also decrease the incidence of IUGR. Encouraging immunocompromised HIV-infected women who plan to become pregnant to wait until immune restoration has been achieved may help to reduce the risk of IUGR. Copyright © 2009 by Lippincott Williams & Wilkins.en_US
dc.subjectMedicineen_US
dc.titleAssociation of low CD4 cell count and intrauterine growth retardation in Thailanden_US
dc.typeJournalen_US
article.title.sourcetitleJournal of Acquired Immune Deficiency Syndromesen_US
article.volume50en_US
article.stream.affiliationsIRD Institut de Recherche pour le Developpementen_US
article.stream.affiliationsHarvard School of Public Healthen_US
article.stream.affiliationsInstitut National d'Etudes Démogaphiquesen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsBanglamung Hospitalen_US
article.stream.affiliationsBhumibol Adulyadej Hospitalen_US
article.stream.affiliationsChiang Kham Hospitalen_US
article.stream.affiliationsChachoengsao Hospitalen_US
article.stream.affiliationsInstitute of research for development, Thailanden_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.